SMS Pharmaceuticals Ltd Quarterly Results

Gross Sales

173.35

196.75

164.45

245.8

161.48

Excise Duty

0

0

0

0

0

Net Sales

173.35

196.75

164.45

245.8

161.48

Other Operating Income

0

0

0

0

0

Other Income

2.13

1.3

1.37

1.65

1.49

Total Income

175.48

198.05

165.82

247.44

162.97

Total Expenditure

140.14

165.28

130.94

212.18

132.48

PBIDT

35.34

32.77

34.88

35.26

30.49

Interest

4.2

4.61

4.67

5.61

5.95

PBDT

31.13

28.16

30.21

29.65

24.54

Depreciation

8.7

8.62

8.38

7.92

8.01

Minority Interest Before NP

0

0

0

0

0

Tax

4.99

4.7

5.3

4.63

4

Deferred Tax

0.37

0.98

0.16

1.06

0.24

Reported Profit After Tax

17.08

13.86

16.37

16.05

12.29

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

18.24

14.1

16.48

17.28

11.48

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

18.24

14.1

16.48

17.28

11.48

EPS (Unit Curr.)

2.15

1.67

1.95

2.04

1.36

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.47

8.47

8.47

8.47

8.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.38

16.65

21.21

14.34

18.88

PBDTM(%)

17.95

14.31

18.37

12.06

15.19

PATM(%)

9.85

7.04

9.95

6.52

7.61